Also, amplification of the epidermal growth factor (EGFR) and loss of phosphatase and tensin homolog (PTEN) can contribute to the malignant phenotype of glioma [72] and the downstream targets, Akt and NF-kB, impact oncogenesis, cell proliferation and apoptosis [73]. This evidence concerns the gene NFKB1 and central nervous system cancer.